Evolution of proviral gp120 over the first year of HIV-1 subtype C infection

Virology

Volumn 383, Issue 1, 2009, Pages 47-59

  Novitsky, Vladimir ^a,b   Lagakos, Stephen ^a   Herzig, Michaela ^a   Bonney, Caitlin ^a   Kebaabetswe, Lemme ^b   Rossenkhan, Raabya ^b   Nkwe, David ^b   Margolin, Lauren ^a   Musonda, Rosemary ^b   Moyo, Sikhulile ^b   Woldegabriel, Elias ^b   van Widenfelt, Erik ^b   Makhema, Joseph ^b   Essex, M ^a,b  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^b BOTSWANA HARVARD AIDS INSTITUTE PARTNERSHIP   (Botswana)

Author keywords

Acute infection; Botswana; Diversification; Diversity; Evolution; gp120; HIV 1 subtype C infection; Provirus

Indexed keywords

GLYCOPROTEIN GP 120; VIRUS RNA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 SUBTYPE C INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MICROBIAL DIVERSITY; MOLECULAR EVOLUTION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; PROTEIN GLYCOSYLATION; SEROCONVERSION; VIRUS REPLICATION;

ADULT; DNA, VIRAL; EVOLUTION, MOLECULAR; FEMALE; HIV ENVELOPE PROTEIN GP120; HIV INFECTIONS; HIV-1; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; MOLECULAR SEQUENCE DATA; PHYLOGENY; PROVIRUSES; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; VIRAL LOAD;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 57149143564     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2008.09.017     Document Type: Article

References (77)

1. Bredell H., Martin D.P., Van Harmelen J., Varsani A., Sheppard H.W., Donovan R., Gray C.M., and Williamson C. HIV type 1 subtype C gag and nef diversity in Southern Africa. AIDS Res. Hum. Retrovir. 23 (2007) 477-481
2. Chohan B., Lang D., Sagar M., Korber B., Lavreys L., Richardson B., and Overbaugh J. Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels. J. Virol. 79 (2005) 6528-6531
3. Choisy M., Woelk C.H., Guegan J.F., and Robertson D.L. Comparative study of adaptive molecular evolution in different human immunodeficiency virus groups and subtypes. J. Virol. 78 (2004) 1962-1970
4. Coetzer M., Cilliers T., Papathanasopoulos M., Ramjee G., Karim S.A., Williamson C., and Morris L. Longitudinal analysis of HIV type 1 subtype C envelope sequences from South Africa. AIDS Res. Hum. Retrovir. 23 (2007) 316-321
5. Delwart E.L., Sheppard H.W., Walker B.D., Goudsmit J., and Mullins J.I. Human immunodeficiency virus type 1 evolution in vivo tracked by DNA heteroduplex mobility assays. J. Virol. 68 (1994) 6672-6683
6. Delwart E., Magierowska M., Royz M., Foley B., Peddada L., Smith R., Heldebrant C., Conrad A., and Busch M. Homogeneous quasispecies in 16 out of 17 individuals during very early HIV-1 primary infection. AIDS 16 (2002) 189-195
7. Derdeyn C.A., Decker J.M., Bibollet-Ruche F., Mokili J.L., Muldoon M., Denham S.A., Heil M.L., Kasolo F., Musonda R., Hahn B.H., Shaw G.M., Korber B.T., Allen S., and Hunter E. Envelope-constrained neutralization-sensitive HIV-1 after heterosexual transmission. Science 303 (2004) 2019-2022
8. Dugan K.A., Lawrence H.S., Hares D.R., Fisher C.L., and Budowle B. An improved method for post-PCR purification for mtDNA sequence analysis. J. Forensic Sci. 47 (2002) 811-818
9. Edgar R.C. MUSCLE: a multiple sequence alignment method with reduced time and space complexity. BMC Bioinformatics 5 (2004) 113
10. Freel S.A., Fiscus S.A., Pilcher C.D., Menezes P., Giner J., Patrick E., Lennox J.L., Hicks Jr. C.B., J.J., and Shugars D.C. Envelope diversity, coreceptor usage and syncytium-inducing phenotype of HIV-1 variants in saliva and blood during primary infection. AIDS 17 (2003) 2025-2033
11. Frost S.D., Liu Y., Pond S.L., Chappey C., Wrin T., Petropoulos C.J., Little S.J., and Richman D.D. Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B. J. Virol. 79 (2005) 6523-6527
12. Gaschen B., Taylor J., Yusim K., Foley B., Gao F., Lang D., Novitsky V., Haynes B., Hahn B.H., Bhattacharya T., and Korber B. Diversity considerations in HIV-1 vaccine selection. Science 296 (2002) 2354-2360
13. Gnanakaran S., Lang D., Daniels M., Bhattacharya T., Derdeyn C.A., and Korber B. Clade-specific differences between human immunodeficiency virus type 1 clades B and C: diversity and correlations in C3-V4 regions of gp120. J. Virol. 81 (2007) 4886-4891
14. Gottlieb G.S., Nickle D.C., Jensen M.A., Wong K.G., Grobler J., Li F., Liu S.L., Rademeyer C., Learn G.H., Karim S.S., Williamson C., Corey L., Margolick J.B., and Mullins J.I. Dual HIV-1 infection associated with rapid disease progression. Lancet 363 (2004) 619-622
15. Gottlieb, G.S., Heath, L., Nickle, D.C., Wong, K.G., Leach, S., Jacobs, B., Gezahegne, S., von't Woul, A.B., Jacobson, L.P., Margolick, J.B., and Mullins, J.I., 2007a. Complex HIV-1 Populations Prior to Seroconversion in MSM: Analysis of HIV-1 Plasma RNA Positive-Seronegative Subjects from the MACS. CROI 2007.
16. Gottlieb G.S., Nickle D.C., Jensen M.A., Wong K.G., Kaslow R.A., Shepherd J.C., Margolick J.B., and Mullins J.I. HIV type 1 superinfection with a dual-tropic virus and rapid progression to AIDS: a case report. Clin. Infect. Dis. 45 (2007) 501-509
17. Gottlieb G.S., Heath L., Nickle D.C., Wong K.G., Leach S.E., Jacobs B., Gezahegne S., van 't Wout A.B., Jacobson L.P., Margolick J.B., and Mullins J.I. HIV-1 variation before seroconversion in men who have sex with men: analysis of acute/early HIV infection in the multicenter AIDS cohort study. J. Infect. Dis. 197 (2008) 1011-1015
18. Gray E.S., Moore P.L., Choge I.A., Decker J.M., Bibollet-Ruche F., Li H., Leseka N., Treurnicht F., Mlisana K., Shaw G.M., Karim S.S.A., Williamson C., Morris L., and the C. S. T. Neutralizing antibody responses in acute human immunodeficiency virus type 1 subtype C infection. J. Virol. 81 (2007) 6187-6196
19. Grobler J., Gray C.M., Rademeyer C., Seoighe C., Ramjee G., Karim S.A., Morris L., and Williamson C. Incidence of HIV-1 dual infection and its association with increased viral load set point in a cohort of HIV-1 subtype C-infected female sex workers. J. Infect. Dis. 190 (2004) 1355-1359
20. Guindon S., and Gascuel O. A simple, fast, and accurate algorithm to estimate large phylogenies by maximum likelihood. Syst. Biol. 52 (2003) 696-704
21. Hall T.A. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl. Acids Symp. Ser. 41 (1999) 95-98
22. Hemelaar J., Gouws E., Ghys P.D., and Osmanov S. Global and regional distribution of HIV-1 genetic subtypes and recombinants in 2004. AIDS 20 (2006) W13-23
23. Herbeck J.T., Nickle D.C., Learn G.H., Gottlieb G.S., Curlin M.E., Heath L., and Mullins J.I. Human immunodeficiency virus type 1 env evolves toward ancestral states upon transmission to a new host. J. Virol. 80 (2006) 1637-1644
24. Herbinger K.H., Gerhardt M., Piyasirisilp S., Mloka D., Arroyo M.A., Hoffmann O., Maboko L., Birx D.L., Mmbando D., McCutchan F.E., and Hoelscher M. Frequency of HIV type 1 dual infection and HIV diversity: analysis of low- and high-risk populations in Mbeya Region, Tanzania. AIDS Res. Hum. Retrovir. 22 (2006) 599-606
25. Johnston M.I., and Fauci A.S. An HIV vaccine-evolving concepts. N. Engl. J. Med. 356 (2007) 2073-2081
26. Jost S., Bernard M.C., Kaiser L., Yerly S., Hirschel B., Samri A., Autran B., Goh L.E., and Perrin L. A patient with HIV-1 superinfection. N. Engl. J. Med. 347 (2002) 731-736
27. Keele B.F., Giorgi E.E., Salazar-Gonzalez J.F., Decker J.M., Pham K.T., Salazar M.G., Sun C., Grayson T., Wang S., Li H., Wei X., Jiang C., Kirchherr J.L., Gao F., Anderson J.A., Ping L.-H., Swanstrom R., Tomaras G.D., Blattner W.A., Goepfert P.A., Kilby J.M., Saag M.S., Delwart E.L., Busch M.P., Cohen M.S., Montefiori D.C., Haynes B.F., Gaschen B., Athreya G.S., Lee H.Y., Wood N., Seoighe C., Perelson A.S., Bhattacharya T., Korber B.T., Hahn B.H., and Shaw G.M. Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection. Proc. Natl. Acad. Sci. U. S. A. 105 (2008) 7552-7557
28. Learn G.H., Muthui D., Brodie S.J., Zhu T., Diem K., Mullins J.I., and Corey L. Virus population homogenization following acute human immunodeficiency virus type 1 infection. J. Virol. 76 (2002) 11953-11959
29. Leitner T., Kumar S., and Albert J. Tempo and mode of nucleotide substitutions in gag and env gene fragments in human immunodeficiency virus type 1 populations with a known transmission history. J. Virol. 71 (1997) 4761-4770
30. Li B., Decker J.M., Johnson R.W., Bibollet-Ruche F., Wei X., Mulenga J., Allen S., Hunter E., Hahn B.H., Shaw G.M., Blackwell J.L., and Derdeyn C.A. Evidence for potent autologous neutralizing antibody titers and compact envelopes in early infection with subtype C human immunodeficiency virus type 1. J. Virol. 80 (2006) 5211-5218
31. Li M., Salazar-Gonzalez J.F., Derdeyn C.A., Morris L., Williamson C., Robinson J.E., Decker J.M., Li Y., Salazar M.G., Polonis V.R., Mlisana K., Karim S.A., Hong K., Greene K.M., Bilska M., Zhou J., Allen S., Chomba E., Mulenga J., Vwalika C., Gao F., Zhang M., Korber B.T.M., Hunter E., Hahn B.H., and Montefiori D.C. Genetic and neutralization properties of subtype C human immunodeficiency virus type 1 molecular env clones from acute and early heterosexually acquired infections in Southern Africa. J. Virol. 80 (2006) 11776-11790
32. Liu S.L., Schacker T., Musey L., Shriner D., McElrath M.J., Corey L., and Mullins J.I. Divergent patterns of progression to AIDS after infection from the same source: human immunodeficiency virus type 1 evolution and antiviral responses. J. Virol. 71 (1997) 4284-4295
33. Lole K.S., Bollinger R.C., Paranjape R.S., Gadkari D., Kulkarni S.S., Novak N.G., Ingersoll R., Sheppard H.W., and Ray S.C. Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J. Virol. 73 (1999) 152-160
34. Long E.M., Martin Jr. H.L., Kreiss J.K., Rainwater S.M., Lavreys L., Jackson D.J., Rakwar J., Mandaliya K., and Overbaugh J. Gender differences in HIV-1 diversity at time of infection. Nat. Med. 6 (2000) 71-75
35. Markham R.B., Wang W.C., Weisstein A.E., Wang Z., Munoz A., Templeton A., Margolick J., Vlahov D., Quinn T., Farzadegan H., and Yu X.F. Patterns of HIV-1 evolution in individuals with differing rates of CD4 T cell decline. Proc. Natl. Acad. Sci. U. S. A. 95 (1998) 12568-12573
36. McCutchan F.E. Global epidemiology of HIV. J. Med. Virol. 78 Suppl. 1 (2006) S7-S12
37. McCutchan, F., Piyasirisilp, S., Hoffmann, O., Sanders-Buell, E., Wilson, G., Tovanabutra, S., Birx, D.L., Hoelscher, M., Maboko, L., 2004. Detecting HIV-1 dual infections in a high-risk cohort in Tanzania. Abstract number TuOrA1139. Int. Conf. AIDS; Bangkok, Tailand; Jul 11-16, 2004.
38. Moore, P.L., Gray, E.S., Choge, I.A., Ranchobe, N., Mlisana, K., Karim, S.S., Williamson, C., Morris, L., 2008. The C3-V4 region is a major target of autologous neutralizing antibodies in hiv-1 subtype C infection. J. Virol. 82, 1860-1869.
39. Ndung'u T., Renjifo B., and Essex M. Construction and analysis of an infectious human immunodeficiency virus type 1 subtype C molecular clone. J. Virol. 75 (2001) 4964-4972
40. Ndung'u T., Renjifo B., Novitsky V.A., McLane M.F., Gaolekwe S., and Essex M. Molecular cloning and biological characterization of full-length HIV-1 subtype C from Botswana. Virology 278 (2000) 390-399
41. Ndung'u T., Sepako E., McLane M.F., Chand F., Bedi K., Gaseitsiwe S., Doualla-Bell F., Peter T., Thior I., Moyo S.M., Gilbert P.B., Novitsky V.A., and Essex M. HIV-1 subtype C in vitro growth and coreceptor utilization. Virology 347 (2006) 247-260
42. Novitsky V., Flores-Villanueva P.O., Chigwedere P., Gaolekwe S., Bussman H., Sebetso G., Marlink R., Yunis E.J., and Essex M. Identification of most frequent HLA class I antigen specificities in Botswana: relevance for HIV vaccine design. Hum. Immunol. 62 (2001) 146-156
43. Novitsky V., Rybak N., McLane M.F., Gilbert P., Chigwedere P., Klein I., Gaolekwe S., Chang S.Y., Peter T., Thior I., Ndung'u T., Vannberg F., Foley B.T., Marlink R., Lee T.H., and Essex M. Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design. J. Virol. 75 (2001) 9210-9228
44. Novitsky V., Cao H., Rybak N., Gilbert P., McLane M.F., Gaolekwe S., Peter T., Thior I., Ndung'u T., Marlink R., Lee T.H., and Essex M. Magnitude and frequency of cytotoxic T-lymphocyte responses: identification of immunodominant regions of human immunodeficiency virus type 1 subtype C. J. Virol. 76 (2002) 10155-10168
45. Novitsky V., Smith U.R., Gilbert P., McLane M.F., Chigwedere P., Williamson C., Ndung'u T., Klein I., Chang S.Y., Peter T., Thior I., Foley B.T., Gaolekwe S., Rybak N., Gaseitsiwe S., Vannberg F., Marlink R., Lee T.H., and Essex M. HIV-1 subtype C molecular phylogeny: consensus sequence for an AIDS vaccine design?. J. Virol. 76 (2002) 5435-5451
46. Novitsky V., Gilbert P., Peter T., McLane M.F., Gaolekwe S., Rybak N., Thior I., Ndung'u T., Marlink R., Lee T.H., and Essex M. Association between virus-specific T-cell responses and plasma viral load in HIV-1 subtype C infection. J. Virol. 77 (2003) 882-890
47. Novitsky V., Wester C.W., DeGruttola V., Bussmann H., Gaseitsiwe S., Thomas A., Moyo S., Musonda R., Widenfelt E., Marlink R.G., and Essex M. The reverse transcriptase 67N 70R 215Y genotype is the predominant TAM pathway associated with virologic failure among HIV-1C-infected adults treated with ZDV/ddI-containing HAART in Southern Africa. AIDS Res. Hum. Retrovir. 23 (2007) 868-878
48. Novitsky V., Woldegabriel E., Wester C., McDonald E., Rossenkhan R., Ketunuti M., Makhema J., Seage III G.R., and Essex M. Identification of primary HIV-1C infection in Botswana. AIDS Care 20 7 (2007) 806-811
49. Osmanov S., Pattou C., Walker N., Schwardlander B., and Esparza J. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000. J. Acquir. Immune Defic. Syndr. Human Retrovirol. 29 (2002) 184-190
50. Posada D., and Crandall K.A. MODELTEST: testing the model of DNA substitution. Bioinformatics 14 (1998) 817-818
51. Posada D., and Buckley T.R. Model selection and model averaging in phylogenetics: advantages of Akaike information criterion and bayesian approaches over likelihood ratio tests. Syst. Biol. 53 (2004) 793-808
52. Poss M., Martin H.L., Kreiss J.K., Granville L., Chohan B., Nyange P., Mandaliya K., and Overbaugh J. Diversity in virus populations from genital secretions and peripheral blood from women recently infected with human immunodeficiency virus type 1. J. Virol. 69 (1995) 8118-8122
53. Rademeyer C., van Harmelen J.H., Ramjee G., Karim S.S., and Williamson C. Heterosexual transmission of multiple highly conserved viral variants in HIV-1 subtype C-infected seronegative women. AIDS 18 (2004) 2096-2098
54. Rademeyer C., Moore P.L., Taylor N., Martin D.P., Choge I.A., Gray E.S., Sheppard H.W., Gray C., Morris L., and Williamson C. Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies. Virology 368 (2007) 172-181
55. Rambaut, A., 2008. FigTree v1.1.2; http://tree.bio.ed.ac.uk/software/figtree.
56. Ritola K., Pilcher C.D., Fiscus S.A., Hoffman N.G., Nelson J.A.E., Kitrinos K.M., Hicks C.B., Eron Jr. J.J., and Swanstrom R. Multiple V1/V2 env variants are frequently present during primary infection with human immunodeficiency virus type 1. J. Virol. 78 (2004) 11208-11218
57. Rong R., Bibollet-Ruche F., Mulenga J., Allen S., Blackwell J.L., and Derdeyn C.A. Role of V1V2 and other human immunodeficiency virus type 1 envelope domains in resistance to autologous neutralization during clade C infection. J. Virol. 81 (2007) 1350-1359
58. Rong R., Gnanakaran S., Decker J.M., Bibollet-Ruche F., Taylor J., Sfakianos J.N., Mokili J.L., Muldoon M., Mulenga J., Allen S., Hahn B.H., Shaw G.M., Blackwell J.L., Korber B.T., Hunter E., and Derdeyn C.A. Unique mutational patterns in the envelope {alpha}2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1. J. Virol. 81 (2007) 5658-5668
59. Rose P.P., and Korber B.T. Detecting hypermutations in viral sequences with an emphasis on G -> A hypermutation. Bioinformatics 16 (2000) 400-401
60. Rousseau C.M., Daniels M.G., Carlson J.M., Kadie C., Crawford H., Prendergast A., Matthews P., Payne R., Rolland M., Raugi D.N., Maust B.S., Learn G.H., Nickle D.C., Coovadia H., Ndung'u T., Frahm N., Brander C., Walker B.D., Goulder P.J.R., Bhattacharya T., Heckerman D.E., Korber B.T., and Mullins J.I. HLA class-I driven evolution of human immunodeficiency virus type 1 subtype C proteome: immune escape and viral load. J. Virol. 82 (2008) 6434-6446
61. Sagar M., Lavreys L., Baeten J.M., Richardson B.A., Mandaliya K., Chohan B.H., Kreiss J.K., and Overbaugh J. Infection with multiple human immunodeficiency virus type 1 variants is associated with faster disease progression. J. Virol. 77 (2003) 12921-12926
62. Salazar-Gonzalez J.F., Bailes E., Pham K.T., Salazar M.G., Guffey M.B., Keele B.F., Derdeyn C.A., Farmer P., Hunter E., Allen S., Manigart O., Mulenga J., Anderson J.A., Swanstrom R., Haynes B.F., Athreya G.S., Korber B.T.M., Sharp P.M., Shaw G.M., and Hahn B.H. Deciphering human immunodeficiency virus type 1 transmission and early envelope diversification by single-genome amplification and sequencing. J. Virol. 82 (2008) 3952-3970
63. Shankarappa R., Margolick J.B., Gange S.J., Rodrigo A.G., Upchurch D., Farzadegan H., Gupta P., Rinaldo C.R., Learn G.H., He X., Huang X.L., and Mullins J.I. Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J. Virol. 73 (1999) 10489-10502
64. Swofford, D.L., (2003)."PAUP*. Phylogenetic Analysis Using Parsimony (*and Other Methods). Version 4.0." Sinauer Associates, Sunderland, Massachusetts.
65. van Harmelen J., Wood R., Lambrick M., Rybicki E.P., Williamson A.L., and Williamson C. An association between HIV-1 subtypes and mode of transmission in Cape Town, South Africa. AIDS 11 (1997) 81-87
66. van Harmelen, J., Bredell, H., Morris, L., van der Ryst, E., Lyons, S., York, D., Williamson, C., 1998. 12th World AIDS Conference, Geneva, Switzerland.
67. van Harmelen J.H., van der Ryst E., Loubser A.S., York D., Madurai S., Lyons S., Wood R., and Williamson C. A predominantly HIV type 1 subtype C-restricted epidemic in South African urban populations. AIDS Res. Hum. Retrovir. 15 (1999) 395-398
68. van Harmelen J., Williamson C., Kim B., Morris L., Carr J., Karim S.S., and McCutchan F. Characterization of full-length HIV type 1 subtype C sequences from South Africa. AIDS Res. Hum. Retrovir. 17 (2001) 1527-1531
69. Williamson S. Adaptation in the env gene of HIV-1 and evolutionary theories of disease progression. Mol. Biol. Evol. 20 (2003) 1318-1325
70. Williamson C., Engelbrecht S., Lambrick M., van Rensburg E., Wood R., Bredell W., and Williamson A.L. HIV-1 subtypes in different risk groups in South Africa. Lancet 346 (1995) 782
71. Williamson C., Morris L., Maughan M.F., Ping L.H., Dryga S.A., Thomas R., Reap E.A., Cilliers T., van Harmelen J., Pascual A., Ramjee G., Gray G., Johnston R., Karim S.A., and Swanstrom R. Characterization and selection of HIV-1 subtype C isolates for use in vaccine development. AIDS Res. Hum. Retrovir. 19 (2003) 133-144
72. Williamson C., Abrahams M., Treurnicht F., Seioghe C., Passmore J.A., Wood N., Mlisana K., Hahn B., Abdool Karim S., and the CAPRISA 002 study and the Center for HIV-AIDS Vaccine Immunology Consortium. Single variant transmission predominates in HIV-1 subtype C infection, with multiple variant transmission associated with increased genital inflammatory cytokines. Abstract 284. 15th CROI (2008), Boston, MA
73. Wolfs T.F., Zwart G., Bakker M., and Goudsmit J. HIV-1 genomic RNA diversification following sexual and parenteral virus transmission. Virology 189 (1992) 103-110
74. Zhang L.Q., MacKenzie P., Cleland A., Holmes E.C., Brown A.J., and Simmonds P. Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection. J. Virol. 67 (1993) 3345-3356
75. Zhang H., Hoffmann F., He J., He X., Kankasa C., Ruprecht R., West J.T., Orti G., and Wood C. Evolution of subtype C HIV-1 Env in a slowly progressing Zambian infant. Retrovirology 2 (2005) 67
76. Zhang H., Hoffmann F., He J., He X., Kankasa C., West J.T., Mitchell C.D., Ruprecht R.M., Orti G., and Wood C. Characterization of HIV-1 subtype C envelope glycoproteins from perinatally infected children with different courses of disease. Retrovirology 3 (2006) 73
77. Zhu T., Mo H., Wang N., Nam D.S., Cao Y., Koup R.A., and Ho D.D. Genotypic and phenotypic characterization of HIV-1 patients with primary infection. Science 261 (1993) 1179-1181